The one metabolic marker that improved alongside the fat measurement, and how the two are connected

Published 26 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
In the pooled phase 3 data, triglycerides fell in the tesamorelin groups relative to placebo over 26 weeks — by around 10 to 15 per cent on average in a population that started with raised levels — and the ratio of total to HDL cholesterol improved, with HDL rising slightly and total and LDL cholesterol changing little. The triglyceride change tracked the visceral fat change: participants who lost more visceral fat tended to show larger falls, consistent with the known relationship between visceral adiposity and triglyceride-rich lipoproteins. The lipid findings were secondary endpoints, and the trials were not designed or powered to show any effect on cardiovascular events.

What was measured

Fasting lipid panels at baseline and at intervals, in a population in which antiretroviral therapy and fat redistribution had raised triglycerides. The treated groups improved; the placebo groups did not. The effect was maintained in those who continued to 52 weeks and reversed in those switched to placebo, like the fat change.

Glucose measures moved in the opposite direction, as the glucose page describes, so the metabolic picture was mixed.

How it connects to fat

Visceral fat drains to the liver and supplies free fatty acids that drive triglyceride-rich lipoprotein production. Reducing the depot reduces the supply, and triglycerides fall; this is seen with weight loss of any cause. Growth hormone also acts directly on hepatic lipid handling. The parallel movement of fat and triglycerides in the trials fits both routes and does not separate them.

The liver fat trials of Stanley and colleagues found related changes in hepatic lipid.

Why it is here

Because the lipid data are the metabolic counterweight to the glucose data and complete the picture of what the trials measured. It describes trial findings and no use of the pack.

Tesamorelin is supplied by REVIVE LAB UAE for laboratory research use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
Tesamorelin Pack20 mgAED 1010In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

What was measured?

Fasting lipid panels at baseline and at intervals, in a population in which antiretroviral therapy and fat redistribution had raised triglycerides. The treated groups improved; the placebo groups did not. The effect was maintained in those who continued to 52 weeks and reversed in those switched to placebo, like the fat change.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

Tesamorelin Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.